Market Data
Market Cap₹645.45 Cr.
52W High₹474.2
Current Price₹409.8
52W Low₹206
Down from 52W High13.6 %
Face Value₹5
Performance
ROCE4.5 %
ROE2.28 %
EPS (TTM)₹2.16
EPS Prev Qtr₹2.87
EPS Last Year₹1.93
EBITDA Qtr₹6.77 Cr.
Book Value₹379
Financial Health
Debt/Equity0.19
Debt/Profit5.79
Total Assets₹818.87 Cr.
Dividend Yield0.12 %
Promoter Holding47.37 %
Earning Power3.37 %
Valuation
Stock P/E32.86
Industry P/E19.54
Price to Book1.08
Price to Sales1.72
Graham Number₹326.29
Key Metrics
__derived
1
Face Value
₹5
About Shivalik Rasayan Ltd
Chemicals · Agro Chemicals
Shivalik Rasayan Ltd is listed on NSE in the Chemicals / Agro Chemicals sector. Face value ₹5. Market cap ₹645.45 Cr.
Price Chart
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| UPL Ltd | - | 22.74 | ₹46,323.79 Cr | 1.09% | ₹2,323 Cr | - | ₹52,804 Cr | - | 11.43% | 0.64 |
| P I Industries Ltd | - | 30.5 | ₹35,539.97 Cr | 0.64% | ₹1,165 Cr | - | ₹6,515.5 Cr | - | 13.35% | 0.02 |
| Sumitomo Chemical India Ltd | - | 37.32 | ₹21,625.49 Cr | 0.3% | ₹579.39 Cr | - | ₹3,244.89 Cr | - | 23.1% | 0 |
| Bayer CropScience Ltd | - | 341.91 | ₹16,503.41 Cr | - | ₹35.06 Cr | - | ₹1,126.38 Cr | - | 3.26% | 0 |
| Sharda Cropchem Ltd | - | 10.51 | ₹6,578.88 Cr | 2.06% | ₹626.21 Cr | - | ₹5,356.54 Cr | - | 25.75% | 0 |
| Dhanuka Agritech Ltd | - | 14.56 | ₹4,253.44 Cr | 0.21% | ₹296.96 Cr | - | ₹2,035.15 Cr | - | 27.49% | 0.03 |
| Rallis India Ltd | - | 23.7 | ₹3,884.52 Cr | 1.5% | ₹164.2 Cr | - | ₹2,603.93 Cr | - | 12.95% | 0.03 |
| NACL Industries Ltd | - | 273.2 | ₹3,199.76 Cr | - | ₹12.37 Cr | - | ₹1,519.43 Cr | - | 5.97% | 0.44 |
| Bhagiradha Chemicals & Industries Ltd | - | 113.25 | ₹3,113.35 Cr | 0.06% | ₹27.52 Cr | - | ₹607.19 Cr | - | 6.11% | 0.33 |
| GSP Crop Science Ltd | - | 19.54 | ₹2,233.13 Cr | 0.21% | ₹98.53 Cr | - | ₹1,526.11 Cr | - | 22.52% | 0.66 |
| Insecticides India Ltd | - | 13.97 | ₹1,748.63 Cr | 0.33% | ₹125.18 Cr | - | ₹2,060.4 Cr | - | 13.62% | 0.12 |
| Bharat Rasayan Ltd | - | 7.66 | ₹1,737.48 Cr | 0.05% | ₹143.29 Cr | - | ₹1,202.6 Cr | - | 15.11% | 0 |
| Astec Lifesciences Ltd | - | - | ₹1,585.87 Cr | - | ₹-66.57 Cr | - | ₹440.62 Cr | - | -4.23% | 1.15 |
| India Pesticides Ltd | - | 14.07 | ₹1,514.98 Cr | 0.57% | ₹107.69 Cr | - | ₹1,034 Cr | - | 14.14% | 0.11 |
| Meghmani Organics Ltd | - | 22.49 | ₹1,447.3 Cr | - | ₹64.24 Cr | - | ₹2,103.17 Cr | - | 7.69% | 0.55 |
| Punjab Chemicals & Crop Protection Ltd | - | 19.57 | ₹1,280.17 Cr | 0.29% | ₹65.4 Cr | - | ₹1,057.53 Cr | - | 18.32% | 0.34 |
| Excel Industries Ltd | - | 16.4 | ₹1,170.02 Cr | 1.48% | ₹71.38 Cr | - | ₹1,078.84 Cr | - | 5.54% | 0 |
| Dharmaj Crop Guard Ltd | - | 16.43 | ₹988.57 Cr | - | ₹60.17 Cr | - | ₹1,152.96 Cr | - | 18.92% | 0.29 |
| Advance Agrolife Ltd | - | 14.2 | ₹780.43 Cr | - | ₹48.9 Cr | - | ₹799.55 Cr | - | 40.99% | 0.79 |
| Heranba Industries Ltd | - | - | ₹718.64 Cr | - | ₹-76.87 Cr | - | ₹1,525.76 Cr | - | -0.8% | 0.75 |
Quarterly Results
📊 Jun 2026: Revenue grew 7.9% YoY, Profit grew 59.0% YoY
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 89.31 | 93.84 | 82.04 | 102.82 | 96.34 |
| ↳ QoQ Growth | - | +5.1% | -12.6% | +25.3% | -6.3% |
| Expenses | 83.14 | 86.54 | 76.78 | 94.55 | 89.57 |
| Operating Profit | 6.17 | 7.3 | 5.26 | 8.27 | 6.77 |
| OPM % | 6.91% | 7.78% | 6.41% | 8.04% | 7.03% |
| Other Income | 0.6 | 0.39 | 1.18 | 1.92 | 0.97 |
| Interest | 2.61 | 2.22 | 2.31 | 2.46 | 2.08 |
| Depreciation | 4.82 | 4.73 | 5.06 | 4.16 | 4.41 |
| EBITDA | 10.99 | 12.03 | 10.32 | 12.43 | 11.18 |
| EBITDA Margin % | 12.31% | 12.82% | 12.58% | 12.09% | 11.6% |
| Profit Before Tax | 4.14 | 5.48 | 4.13 | 7.73 | 5.66 |
| Tax % | 32.13% | 21.35% | 11.14% | 7.12% | 20.49% |
| Net Profit | 2.83 | 4.3 | 3.67 | 7.17 | 4.5 |
| ↳ QoQ Growth | - | +51.9% | -14.7% | +95.4% | -37.2% |
| EPS | 1.19 | 1.93 | 1.71 | 2.87 | 2.16 |
Profit & Loss
| Mar 2026 | TTM | |
|---|---|---|
| Sales | 368.01 | 375.04 |
| Expenses | 341.01 | 347.44 |
| Operating Profit | 27 | 27.6 |
| OPM % | 7.34% | 7.36% |
| Other Income | 4.09 | 4.46 |
| Interest | 9.6 | 9.07 |
| Depreciation | 18.77 | 18.36 |
| Profit Before Tax | 21.48 | 23 |
| Tax % | 16.34% | 14.52% |
| Net Profit | 17.97 | 19.64 |
| EPS | 7.7 | 8.67 |
Compounded Sales Growth
10Y
-
5Y
-
3Y
-
TTM
-
Compounded Profit Growth
10Y
-
5Y
-
3Y
-
TTM
-
Stock Price CAGR
10Y
-
5Y
-
3Y
-
1Y
-5.74%
Return on Equity
10Y
-
5Y
-
3Y
-
Last Year
3.66%
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 7.8752 | 7.88 |
| Reserves | 528.3618 | 591.23 |
| Borrowings | 93.88 | 113.64 |
| Other Liabilities | 104.17 | 106.12 |
| Total Liabilities | 734.2907 | 818.87 |
| Fixed Assets | 336.6438 | 334 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 397.65 | 484.87 |
| Total Assets | 734.2907 | 818.87 |
Cash Flows
| Mar 2025 | |
|---|---|
| Cash from Operating Activity | -9.2026 |
| Cash from Investing Activity | -21.1084 |
| Cash from Financing Activity | 20.543 |
| Net Cash Flow | -9.768 |
Ratios
| Mar 2026 | |
|---|---|
| Debtor Days | - |
| Inventory Days | - |
| Days Payable | - |
| Cash Conversion Cycle | - |
| Working Capital Days | 699.46 |
| ROCE % | 3.83% |
Shareholding Pattern
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Promoters % | 47.37% | 47.37% | 47.37% | 47.37% |
| FIIs % | 4.38% | 3.89% | 4.2% | 1.19% |
| DIIs % | 0.48% | 0.12% | 0% | 0.02% |
| Public % | 31.06% | 31.95% | 31.84% | 33.97% |
| No. of Shareholders | 14,199 | 14,013 | 13,413 | 14,104 |
Major Shareholders (>1%)
- Growel Remedies LimitedPromoter and Promoter Group47.37%
- Ginnerup Capital ApsPublic Shareholding3.22%
- Eric Aarestrup SorensenPublic Shareholding2.13%
- Ritesh Kantilal OswalPublic Shareholding1.02%
As of 2026-06-30View all shareholders →